الفهرس | Only 14 pages are availabe for public view |
Abstract As OCT has revolutionized the clinical management of ophthalmic diseases, intraoperative OCT is potentially poised as a game-changing technology in the operating room. Over the past few years, significant advances in integrative technology have paved the way to first generation commercial systems. Future platforms will need to prioritize surgeon interaction, image quality, and overall data analysis to the value of this technology. Emerging therapies, such as gene therapy and stem cell therapy, may provide unique opportunities for targeted image-guided delivery with confirmatory imaging of optimal placement. Immediate surgeon feedback regarding the surgical environment may facilitate the transition to more novel procedures for surgeons. Continuing research and development is still needed for intraoperative OCT but early studies suggest that this technology may represent a unique opportunity for individualized enhanced patient care. |